Tuesday, Dec 11, 2018 Current Time: 11:08:14 AM (BST) Market Status: Open
1JANATAMF 4.40 
0.00    0.00%

1STPRIMFMF 10.40 
0.10    0.97%

AAMRATECH 28.20 
0.50    1.81%

ABBANK 11.50 
0.00    0.00%

ACI   331.00    
5.30    1.63%

ACIFORMULA 156.00 
3.60    2.36%

ACTIVEFINE 27.80 
0.10    0.36%

AFTABAUTO 44.70 
-0.10    -0.22%

AGNISYSL 20.00 
-0.10    -0.50%

AL-HAJTEX 92.10 
0.40    0.44%

ALIF   9.40    
0.00    0.00%

ALLTEX 14.70 
1.30    9.70%

AMANFEED 48.60 
0.50    1.04%

AMBEEPHA 825.20 
-31.90    -3.72%

AMCL(PRAN) 242.00 
-3.10    -1.26%

ANLIMAYARN 34.50 
1.00    2.99%

ANWARGALV 75.90 
2.20    2.99%

APEXFOODS 176.70 
-0.50    -0.28%

APEXFOOT 285.00 
2.20    0.78%

APEXSPINN 136.90 
0.90    0.66%

APEXTANRY 142.50 
0.00    0.00%

APOLOISPAT 7.70 
0.00    0.00%

ARAMIT 458.20 
-3.30    -0.72%

ARGONDENIM 26.00 
0.50    1.96%

ASIAINS 17.30 
0.10    0.58%

ASIAPACINS 23.10 
0.40    1.76%

ATLASBANG 130.00 
1.60    1.25%

AZIZPIPES 180.30 
-2.30    -1.26%

BANGAS 340.00 
2.10    0.62%

BANKASIA 17.40 
0.10    0.58%

BBS   28.50    
-0.10    -0.35%

BBSCABLES 93.30 
1.20    1.30%

BDAUTOCA 245.50 
4.60    1.91%

BDCOM   26.00    
0.10    0.39%

BDFINANCE 15.80 
0.20    1.28%

BDLAMPS 216.50 
-0.90    -0.41%

BDTHAI 21.50 
0.00    0.00%

BEACHHATCH 11.30 
-0.10    -0.88%

BEACONPHAR 16.60 
0.20    1.22%

BENGALWTL 28.50 
0.30    1.06%

BERGERPBL 1362.00 
-2.00    -0.15%

BEXIMCO 21.60 
0.00    0.00%

BGIC   19.30    
-0.70    -3.50%

BRACBANK 73.80 
-0.50    -0.67%

BSC   39.50    
0.20    0.51%

BSCCL   86.50    
1.00    1.17%

BSRMSTEEL 60.40 
0.80    1.34%

BXPHARMA 75.90 
0.90    1.20%

BXSYNTH 6.50 
0.00    0.00%

CENTRALPHL 14.60 
0.10    0.69%

CITYBANK 30.50 
-0.10    -0.33%

CITYGENINS 12.90 
-0.20    -1.53%

CONFIDCEM 184.70 
0.00    0.00%

CVOPRL 163.70 
1.70    1.05%

DACCADYE 5.40 
0.10    1.89%

DOREENPWR 80.40 
0.70    0.88%

LHBL   43.50    
0.70    1.64%

NAHEEACP 58.40 
0.90    1.57%

NURANI 16.90 
0.10    0.60%

QUASEMIND 44.00 
-0.30    -0.68%

QUEENSOUTH 42.40 
0.70    1.68%

SEMLLECMF 6.70 
0.00    0.00%

UCB   16.80    
-0.10    -0.59%

VFSTDL 61.70 
3.40    5.83%

YPL   13.80    
0.50    3.76%


Increase the speed of the ticker
Set the ticker's scrolling direction to right
 
Market Highlights
Market Price
Top 20 Shares
DSEX  
DS30
News
Latest Share Price
By Trade Code
By % Change
By Value
By Volume
By Last Trade Price
By Category
By Alphabetic Order
In Text Mode
DEBT Board
Search Company
 
Enter Company's Trading code

Company Name: GlaxoSmithKline(GSK) Bangladesh Ltd.
Company Information
Untitled Document
Trading Code: GLAXOSMITH Scrip Code: 18454
Untitled Document
Figure in BDT    
Market Information: Dec 11, 2018

Last Trading Price 1,580.00
Last Update 11:08 AM
Change*
-25.8
-1.61%
Opening Price 1,610.00
Adjusted Opening Price 1,605.80
Yesterday's Closing Price 1,605.80
Closing Price -
Day's Range 1,580.00 - 1,610.00
Day's Value (mn) 1.698
52 Weeks' Moving Range 1,005.00 - 1,745.00
Day's Volume (Nos.) 1,069
Day's Trade (Nos.) 77
Market Capitalization (mn) 19,344.188
*Based on Yesterday's Closing Price and Last Trading Price.

Basic Information

Authorized Capital (mn) 200.00
Paid-up Capital (mn) 120.46
Face/par Value 10.0
Total No. of Outstanding Securities 12,046,449
Debut Trading Date
Type of Instrument Equity
Market Lot 1
Sector Pharmaceuticals & Chemicals
Untitled Document
Closing Price Graph:     Total Trade Graph:     Total Volume Graph:    

Last AGM held on: 19/04/2018
For the year ended: Dec 31, 2017

Cash Dividend 550% 2017, 500% 2016, 550% 2015
Bonus Issue (Stock Dividend) n/a
Right Issue n/a
Year End 31-Dec
Reserve & Surplus without OCI (mn) 2,509.89
Other Comprehensive Income (OCI) (mn) 0.0

 

Interim Financial Performance: 2018

Particulars Unaudited / Audited
Q1 Q2 Half Yearly Q3 9 Months
201809
Annual
Ending on Ending on 6 Months
201806
Ending on Ending on
201803 201806 201809
Turnover/Revenue (mn) 1750.71 1626.63 3377.34 0 0Mismatch is due
to issuer's own
actual disclosure
-
Profit from continuing operations (mn) 138.42 43.97 182.39 0 0Mismatch is due
to issuer's own
actual disclosure
-
Profit for the period (mn) 138.42 43.97 182.39 0 0Mismatch is due
to issuer's own
actual disclosure
-
Total Comprehensive Income for the period (mn) 138.42 43.97 182.39 0 0Mismatch is due
to issuer's own
actual disclosure
-
Earnings Per Share (EPS)
Basic 11.490 3.650 15.140 -48.640 -33.500Mismatch is due
to issuer's own
actual disclosure
-
Diluted* - - - - - -
Earnings Per Share (EPS) - continuing operations
Basic 11.490 3.650 15.140 -48.640 -33.500Mismatch is due
to issuer's own
actual disclosure
-
Diluted* - - - - - -
Market price per share at period end 1452.8 1447.9 1447.9 1195.8 1195.8 -
*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.

Price Earnings (P/E) Ratio based on latest Un-audited Financial Statements

Particulars Dec 03, 2018Dec 04, 2018Dec 05, 2018Dec 06, 2018Dec 09, 2018Dec 10, 2018
Current P/E Ratio using Basic EPS
(Continuing core operations)**
------
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------

 

Price Earnings (P/E) Ratio Based on latest Audited Financial Statements

Particulars Dec 03, 2018Dec 04, 2018Dec 05, 2018Dec 06, 2018Dec 09, 2018Dec 10, 2018
Current P/E Ratio using Basic EPS
(Continuing core operations)**
24.726.2427.8829.6230.0428.9
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------
** Usually refers to "Continuing operations".
*** Calculated using bonus-adjusted number of shares as per BSEC Directive (not as per IAS 33 or BAS 33).

Financial Performance as per Audited Financial Statements as per IFRS/IAS or BFRS/BAS

Year Earnings per share(EPS) EPS - Continuing Operations NAV Per Share Profit/(Loss) and OCI
Basic Diluted
Basic Diluted
PCO* Profit for the year (mn) TCI*
Original Restated Original Restated Original Restated Diluted
2013 - - - 45.35 - - 153.66 - - 546.25 - -
2014 - - - 68.63 - - 192.30 - - 826.78 - -
2015 - - - 68.99 - - 216.15 - - 831.08 831.08 855.80
2016 - - - 53.51 - - 214.65 - - 644.55 644.55 644.55
2017 - - - 55.56 - - 218.35 - - 669.30 669.30 669.30
PCO = Profit from Continuing Operations (mn)
TCI = Total Comprehensive Income for the year (mn)

Financial Performance... (Continued)

Year Year end Price Earnings (P/E) ratio Dividend in %* Dividend Yield in %
Earnings per share(EPS) EPS - Continuing Operations
Using Basic EPS Using
Diluted EPS
Using Basic EPS Using
Diluted EPS
Original Restated
Original Restated
2013 - - - 21.07 21.07 - 300.00 3.14
2014 - - - 22.03 22.03 - 420.00 2.78
2015 - - - 26.09 - - 550.00 3.06
2016 - - - 28.65 - - 500.00 3.26
2017 - - - 27.91 - - 550.00 3.55
*B for bonus or stock dividend, otherwise cash.
*Note: Price Earnings (P/E) Ratio has been calculated as per annual financial statements submitted by the listed securities by adopting uniform income year from July to June in compliance with the provisions of the Finance Act, 2015 and BSEC Directive No. SEC/SRMIC/2011/1240/445 dated April 27, 2016. For the first time adoption of the change in the financial year, listed companies, those year-ended on March, April, July, August, September, October and December, submitted their audited accounts by adding next few months or reducing few months and P/E has been calculated accordingly.
Details of Financial Statement http://www.gsk.com.bd/publications/quarterly-reports.aspx
Price Sensitive Information http://www.gsk.com.bd/investors/

 

Other Information of the Company

Listing Year 1976
Market Category A
Electronic Share Y
Share Holding Percentage [as on Dec 31, 2017 (year ended)]
Sponsor/Director:
81.98
Govt:
0.00
Institute:
15.98
Foreign:
0.74
Public:
1.30
Share Holding Percentage [as on Oct 31, 2018]
Sponsor/Director:
81.98
Govt:
0.00
Institute:
15.57
Foreign:
1.24
Public:
1.21
Share Holding Percentage [as on Nov 30, 2018]
Sponsor/Director:
81.98
Govt:
0.00
Institute:
15.59
Foreign:
1.24
Public:
1.19
Remarks TK 59,479,000 Revaluation Reserve has been added to Reserve & Surplus.
Note: This is information for the concerned that total holdings of Sponsors/Directors of most of the listed securities have changed from the month of June, 2016 than that of earlier reporting mainly due to compliance of the regulation 2(r) of the Dhaka Stock Exchange (Listing) Regulations, 2015 which reads QUOTE Sponsor means any person or institution who subscribes to the initial capital of a company or a mutual fund or a collective investment scheme. UNQUOTE
Corporate Performance at a glance

Present Operational Status Active
Present Loan Status as on December 31, 2017
  Short-term loan (mn) 0.00
Long-term loan (mn) 0.00
Latest Dividend Status (%) 550.00 for 2017
Latest Credit Rating Status
  Short-term
Long-term
OTC/Delisting/Relisting

 

Address of the Company

Address House # 2A, Road # 138, Gulshan - 01, Dhaka - 1212
Contact Phone 9858870-75
Fax 88 - 02 - 8826628
E-mail gsk.bangladesh-info@gsk.com
Web Address http://www.gsk.com.bd

Note: All dynamic information of this page are only valid for Public and Debt board.
Disclaimer: This page is now under updating process. If any anomalies are found , please inform us (phone: 88-02-9564601, 7175703-11, Ext- 259).

 




STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
 

Home | Download | Data Archives | Career at DSE | FAQ | Sitemap | Links
Disclaimer Copyright Dhaka Stock Exchange 2011 Terms & Conditions
 

Powered By Bangladesh Online a division of Bangladesh Export Import Company Ltd.